BD

CIK 0000010795 · BDX NYSE

SIC
3841 · Surgical and Medical Instruments
Type
Operating
Status
Public
Filer
Large accelerated filer
Incorporated
New Jersey
FY End
Sep 30

Business Summary

Becton, Dickinson and Company (BD) is a global medical technology company incorporated in New Jersey in 1897, engaged in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. BD serves healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry, and the general public across more than 190 countries. As of fiscal year 2025 (ended September 30, 2025), BD employed approximately 72,000 associates in 61 countries.

BD operated three business segments during FY2025: BD Medical, BD Life Sciences, and BD Interventional. Effective October 1, 2025, BD reorganized into five segments: Medical Essentials, Connected Care, BioPharma Systems, Interventional, and Life Sciences. A transformative strategic event in FY2025 was the July 2025 announcement of a Reverse Morris Trust transaction to combine BD's Biosciences and Diagnostic Solutions businesses with Waters Corporation, with BD expected to receive approximately $4 billion cash and BD shareholders to...

Get a free account in seconds to read the full business overview. Create free account

AI-generated summary of Item 1 (Business) from the 10-K filed Nov 25, 2025 — View filing on SEC.gov. May contain errors — refer to the filing for authoritative information.

Across SEC filings

Institutional holders · 13F

Q2 2026
1,452 managers reported a position for Q2 2026 -30 vs Q1 2026
Largest Q2 2026 Form 13F holders of BD by reported value
Largest holders Reported value
BlackRock Inc $3.7B
VANGUARD CAPITAL MANAGEMENT LLC $2.7B
MASSACHUSETTS FINANCIAL SERVICES CO MA $2.5B
STATE STREET CORPORATION $2.3B
VANGUARD PORTFOLIO MANAGEMENT LLC $2.3B

Annual results · 10-K

Fiscal 2025
Revenue
$21.8B
Net income
$1.7B

As reported in the fiscal 2025 annual report.

Funds & ETFs · N-PORT

Loading fund holders…

Securities

Securities issued by this company
CUSIP Security Type
075887109 BDX BECTON DICKINSON & CO Common stock
075887117 BECTON DICKINSON & CO Common stock
075887208 BDXA BECTON DICKINSON AND CO Preferred stock
075887406 BDXB BECTON DICKINSON & CO Preferred stock

Insider trades · Form 4

-$2.75M net open-market insider transactions, last 12 months 0 filings with purchases ($0), 20 filings with sales ($2.75M)

Latest filings

5%+ holders · 13D/G

4 filers
Schedule 13D and 13G filers reporting a stake of 5% or more
Filer % of class Filed
STATE STREET CORPORATION 13G 5.4% 2026-08-07
First Eagle Investment Management LLC 13G 5.1% 2026-08-06
VANGUARD CAPITAL MANAGEMENT LLC 13G 7.5% 2026-04-29
VANGUARD PORTFOLIO MANAGEMENT LLC 13G 5.4% 2026-04-29

Latest Schedule 13D or 13G from each filer; stakes a filer has reported closed are left out.

Federal lobbying · LD-2

$3.3M reported spend, four quarters through Q3 2026

Latest SEC filings

All filings →
Latest SEC filings by BD
Form Description Filed
144 144 2026-11-05
8-K Current Report 2026-11-05
4 Insider Transaction · Michael Feld 2026-10-27
144 144 2026-10-26
4 Insider Transaction · Michael Feld 2026-09-29
144 144 2026-09-28
4 Insider Transaction · Vitor Roque 2026-09-03
4 Insider Transaction · Michael Feld 2026-08-27
144 144 2026-08-26
4 Insider Transaction · Michael Feld 2026-08-24
Loading ownership data...
Loading insider trading data...
Loading financials...

Quality is a Plus feature

See why the score is what it is — the score history and the full test-by-test breakdown behind the composite.

Valuation is a Premium feature

What this company is worth versus its price — fair value at today's bond rate, margin of safety, and the Graham Number against the institutional consensus price.

Loading SEC filings...
Loading sponsor profile...